Goulandris Brothers Limited

Date authorised
1 April 2013
Companies House
00521607
Last scraped
3 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    21 Queen Anne's Gate
    London
    London
    SW1H 9BU
    UNITED KINGDOM
    Phone
    +4402072225244

  • Complaints Contact

    21 Queen Anne's Gate
    London
    London
    SW1H 9BU
    UNITED KINGDOM
    Phone
    +4402072225244

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • P2P Lending Advice

    For Commercial, Eligible Counterparty, Professional

  • Investment Advice (no pensions)

    For Commercial, Eligible Counterparty, Professional, Certificates representing certain security, Debenture, Government and public security, Non-investment insurance contracts, Share, Warrant

    Show 1 limitation
    • · Investment activity in "rights to or interests in investments (security)" and "rights to or interests in investments (contractually based investment)" is limited to the investment types granted for this activity.

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.

  • Arranges Investments

    For Commercial, Non-investment insurance contracts

  • Insurance Admin

    For Commercial, Non-investment insurance contracts

  • Stockbroking

    For Commercial, Non-investment insurance contracts

  • Investment Setup

    For Commercial, Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Christopher Robert MacLean

    IRN CRM01037

    • CF1 Director (1 Dec 2001 to 5 Sep 2006)
  • Constantine Basil Goulandris

    IRN CBG01013

    • CF3 Chief Executive (1 Dec 2001 to 30 Mar 2007)
    • CF8 Apportionment and Oversight (1 Dec 2001 to 30 Mar 2007)
    • CF1 Director (1 Dec 2001 to 30 Mar 2007)
  • George John Goulandris

    IRN GJG01039

    • SMF3 Executive Director (9 Dec 2019 to 1 Jan 2023)
    • CF30 Customer (1 Nov 2007 to 8 Dec 2019)
    • CF1 Director (1 Dec 2001 to 8 Dec 2019)
    • CF21 Investment Adviser (1 Dec 2001 to 31 Oct 2007)
  • Leonardo Constantine Goulandris

    IRN LCG01008

    • [FCA CF] Significant management (since 16 Mar 2021)
    • SMF3 Executive Director (since 9 Dec 2019)
    • SMF1 Chief Executive (since 9 Dec 2019)
    • CF3 Chief Executive (5 Apr 2007 to 8 Dec 2019)
    • CF8 Apportionment and Oversight (5 Apr 2007 to 31 Mar 2009)
    • CF1 Director (26 Sep 2006 to 8 Dec 2019)
  • Nigel Haig-Brown

    IRN NXH01139

    • CF28 Systems and controls (1 Nov 2007 to 8 Dec 2019)
    • CF13 Finance (1 Dec 2001 to 31 Oct 2007)
  • Robert James Wadsworth

    IRN RJW01180

    • [FCA CF] Significant management (since 15 Mar 2021)
    • SMF17 Money Laundering Reporting Officer (MLRO) (since 9 Dec 2019)
    • SMF3 Executive Director (since 9 Dec 2019)
    • SMF16 Compliance Oversight (since 9 Dec 2019)
    • Responsible for Insurance Distribution (since 1 Oct 2018)
    • CF1 Director (14 Sep 2006 to 8 Dec 2019)
    • Responsible for Insurance Mediation (14 Jan 2005 to 30 Sep 2018)
    • CF10 Compliance Oversight (1 Dec 2001 to 8 Dec 2019)
    • CF11 Money Laundering Reporting (1 Dec 2001 to 8 Dec 2019)
  • Thomas Bradley

    IRN TXB01092

    • CF1 Director (1 Dec 2001 to 31 Mar 2002)

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.